Tip:
Highlight text to annotate it
X
>> GOOD MORNING.
MY NAME IS DR. RAJ SAHULEE FROM ICAHN SCHOOL
OF MEDICINE AT MOUNT SINAI.
FOR OUR STUDY WE CHOSE TO LOOK AT DIFFERENCES IN HEART
TRANSPLANT RECIPIENT OUTCOME BASED ON CDC HIGH-RISK DONOR
GRAFT STATUS.
WE FOUND THAT IN ALL PEDIATRIC HEART
TRANSPLANTATION, 4.1% USED CDC HIGH-RISK DONOR GRAFTS;
HOWEVER, WE FOUND THAT THERE WAS NO DIFFERENCE IN
CUMULATIVE SURVIVAL BETWEEN HIGH-RISK DONOR GRAFT
RECIPIENTS AND STANDARD- RISK DONOR GRAFT RECIPIENTS.
FURTHERMORE, WE FOUND OUT THAT THERE WAS NO
SIGNIFICANT DIFFERENCE IN PERIOPERATIVE MORBIDITIES,
SUCH AS LENGTH OF STAY AFTER TRANSPLANTATION,
AS WELL AS, EPISODES OF REJECTION PRIOR
TO DISCHARGE.
OUR STUDY CONCLUDES THAT THERE'S NO SIGNIFICANT
EFFECT OF CDC HIGH- RISK DONOR STATUS
ON RECIPIENT OUTCOME.